70. Antifungal Agents in Children
Session: Symposium: Invasive Fungal Infections in Children
Thursday, October 18, 2012: 9:15 AM
Room: SDCC 33 ABC
William Steinbach, MD, FIDSA, Duke University Medical Center, Durham, NC

Biography - William J. Steinbach, MD
Duke University Medical Center
Dr. Steinbach is an Associate Professor of Pediatrics (Pediatric Infectious Diseases), Molecular Genetics and Microbiology at Duke University Medical Center. He is the Director of the Duke University Aspergillus Pathogenesis Laboratory and his research interests include both clinical investigation and basic science advances. His NIH-funded laboratory efforts at Duke focus on stress response pathways in A. fumigatus as a means to deciphering virulence factors and improving antifungal therapy outcomes. In addition to his molecular genetic and animal model research, Dr. Steinbach designs and performs phase I-IV clinical trials in antifungal therapy for adults and children. His specific clinical interests focus on optimizing the understanding and treatment of invasive aspergillosis, including evaluating promising new therapeutic advances. His pediatric clinical specialty centers on the epidemiology, diagnosis, and treatment of pediatric fungal infections, including the unique facets of these patients compared to adult patients.
Dr. Steinbach graduated from the University of Notre Dame and the University of North Carolina School of Medicine. He then completed his pediatric residency training at Stanford University where he was named one of 12 fellows from all pediatric disciplines in the NIH Pediatric Scientist Development Program. After Stanford, he completed his pediatric infectious diseases fellowship at Duke University, and then continued at Duke on faculty. Dr. Steinbach completed a sabbatical at the Unité des Aspergillus at the Institute Pasteur in Paris in 2004, and also completed another sabbatical at the University of Perugia in Italy in 2007 studying host cell responses to Aspergillus fumigatus.
Dr. Steinbach is the recipient of several Young Investigator Awards, a member of numerous professional societies, is on the editorial board of three journals, reviews for over two dozen journals, lectures around the world on invasive fungal infections and antifungals, and has been the lead guest editor of three dedicated supplements on invasive aspergillosis. He was the co-founder and continues as the co-chairman of the international Advances Against Aspergillosis conference. He is the co-editor of the American Society for Microbiology new textbook “Aspergillus fumigatus and Aspergillosis” recently published. Dr. Steinbach is also the founder and director of the International Pediatric Fungal Network, an international consortium of over 60 sites dedicated to investigating pediatric invasive fungal infections (http://pfn.pediatrics.duke.edu). Most importantly, Dr. Steinbach also coaches both his son and daughter’s soccer teams.



Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.